Your Pain Meds’ Side Effects May Be Masquerading as Heart Failure
Matthew Growdon's study finds "prescription cascades" where drug side effects lead to unnecessary second prescriptions, causing further harm and costly hospitalizations.
University of California San Francisco
Give to UCSF
Displaying 1 - 30 of 493
-
-
How to Thwart Cancer: Drug the Cells It Uses to Grow and Shapeshift
Senescent fibroblasts are aging cells in connective tissue that no longer divide and protect against tumor development. Yet, these same cells can promote cancer growth in a laboratory setting.Until
-
How Nursing Home Residents Got Caught in the Opioid Backlash
Doctors have reduced opioid prescribing since the opioid epidemic’s peak, but a UCSF study found that this trend affects nursing home residents with chronic pain. An analysis of 3M residents saw declines in opioid use, with racial disparities in prescribing.
-
Opportunity Rx: Could This Be a New Path Out of Pharmacy Deserts?
The UCSF School of Pharmacy's inaugural PharmTech to PharmD pathway program provides one-on-one mentoring to roughly three dozen pharmacy technicians who aspire to become pharmacists, and guarantees successful participants an interview at UCSF. The program hopes to provide pathways to well-paying jobs and help fill gaps in access to health care in California.
-
How to Keep Cells Out of Limbo and Prevent Lung Scarring
Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of blocking it to halt progression of the disease.
-
Novel Immunotherapy Combination Destroys Colorectal Liver Metastases
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to
-
Could This Novel Therapy Calm Anxiety for Millions of Americans?
Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point that they rarely leave their home.
-
Novel Therapy Aims to Make Type 1 Diabetes Patients Insulin Free
UCSF Health transplant specialists recently performed an innovative, minimally invasive pancreatic islet transplant designed to enable a patient with Type 1 diabetes to become insulin independent.
-
How 100,000 Grandmas Fight Cancer in Every Human Cell
A TED Talk-style presentation on the effects of tangled DNA strands took first place at this year's Postdoc Slam competition, which is held in celebration of National Postdoc Appreciation Week.
-
UCSF Awarded $12M Research Grant to Improve Cancer Outcomes
The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a
-
Repurposing a Diabetes Medication to Prime CAR T Cancer Targets
Urothelial carcinoma (UC) is the second most common genitourinary cancer, leading to over 16,000 deaths a year in the U.S. Despite recent advances, the five-year survival rate for metastatic UC
-
First Global Guidelines for Pregnancy and Inflammatory Bowel Disease Developed
For women with inflammatory bowel disease (IBD), pregnancy can be an uncertain time due to limited clinical data about how IBD medications impact pregnancy outcomes and infants who have been exposed
-
This Chemical Trick Could Turn Losing Malaria Drug Into a Winner
A UCSF team develops a new drug for malaria that could address one of the disease's biggest challenges - the spread of parasites that resist the most commonly-used medications.
-
How UCSF Is Helping African Infectious Disease Researchers Take the Lead
UC San Francisco’s Paul Farmer African Initiative for Research (PFAIR) supports African scientists in infectious disease research via mentorship, international collaboration, and sustainable funding.
-
UCSF Experts Featured at National Endocrinology Meeting
Endocrine disruption during pregnancy and genetic drivers of bone disease were among the topics experts from UC San Francisco presented at the annual meeting of the Endocrine Society — ENDO 2025 — in
-
A CRISPR Approach to Neurodegenerative Diseases
The Byers Award recognizes outstanding research by faculty members in the middle of their careers. Martin Kampman’s honorary 2025 lecture is titled “A CRISPR approach to neurodegenerative diseases.”
-
The Most Effective Diabetes Drugs Don’t Reach Enough Patients Yet
A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
-
This is How AI Can Help Us Make New Medicines Faster
UCSF researchers recently created the world's first shape-shifting synthetic proteins using artificial intelligence (AI). The breakthrough opens the door to developing entirely new proteins that could, one day, produce medicines to stop diseases like cancer.
-
Maria Lopez, PharmD ’01: Community Pharmacy Pioneer
Maria Lopez, PharmD ’01, didn’t just want to own a pharmacy – she wanted to redefine what one could be. “I wanted to create something different, something more personal,” says Lopez, the 2025 Alumni Humanitarian Service Award winner.
-
Five Questions for Joanne Chun
The School of Pharmacy’s Joanne Chun, PharmD ’93, PhD ’96, leads a new master’s degree program focused on AI’s transformation of drug discovery and development.
-
The Quest to Reinvent Anesthesia
UCSF researchers are scouring millions of compounds – with help from tiny zebrafish – to create anesthetics safe enough to use without an anesthesiologist.
-
An Artificial Protein that Moves Like Something Found in Nature
Researchers at UCSF have shown it is possible to make new proteins that move and change shape like those in nature. This ability will help scientists engineer proteins in powerful new ways to treat disease, clean up pollution, and increase crop yields.
-
AI in Cancer Care, Targeted Therapies Among Cancer Conference Talks
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapies, cancer genomics, using AI to personalize cancer treatment, improving diagnosis of hard-to-treat
-
Diabetes Medication May Increase Risk of Perioperative Ketoacidosis
Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes mellitus (T2DM). They are designed to lower high blood glucose levels
-
Could this Molecule be ‘Checkmate’ for Coronaviruses like SARS-CoV-2?
A team at UCSF and Gladstone Institutes developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could cause future pandemics.
-
Stephen Hauser Wins Breakthrough Prize for Role in Redefining MS
Neuro-immunologist Stephen Hauser, MD, whose maverick thinking transformed the treatment landscape for patients with multiple sclerosis (MS), has received the 2025 Breakthrough Prize in Life Sciences.
-
How Your Brain Manages Cholesterol Could Increase Alzheimer’s Risk
Alzheimer’s disease is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like changes in sleep, anxiety and depression can be early signs of the disease.
-
Researchers Learn How a Drug Called Zotatifin Kills Cancer Cells
A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.
-
NIH Funding Drives UCSF’s Pursuit of Better Health for All
UCSF received $815 million in awards from the National Institutes of Health (NIH) last year for research that will improve the lives of patients in the U.S. and around the world.
-
Injectable Therapy Is ‘Magic’ for Those Who Can’t Take HIV Pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found.
